CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,263,736 | -33.7% | 108,104 | -23.8% | 0.00% | -50.0% |
| Q2 2023 | $1,906,168 | +34.3% | 141,828 | +65.7% | 0.00% | +100.0% |
| Q1 2023 | $1,419,247 | -8.3% | 85,600 | +2.8% | 0.00% | -50.0% |
| Q4 2022 | $1,548,468 | +48.2% | 83,251 | +2.2% | 0.00% | +100.0% |
| Q3 2022 | $1,045,000 | +115.0% | 81,446 | +17.5% | 0.00% | 0.0% |
| Q2 2022 | $486,000 | -18.7% | 69,308 | -4.0% | 0.00% | 0.0% |
| Q1 2022 | $598,000 | +19.4% | 72,195 | -2.5% | 0.00% | – |
| Q4 2021 | $501,000 | +33.2% | 74,072 | +4.3% | 0.00% | – |
| Q3 2021 | $376,000 | +1.9% | 71,025 | +10.7% | 0.00% | – |
| Q2 2021 | $369,000 | -7.5% | 64,157 | -25.9% | 0.00% | – |
| Q1 2021 | $399,000 | -38.2% | 86,638 | -55.2% | 0.00% | – |
| Q4 2020 | $646,000 | -29.0% | 193,544 | -36.8% | 0.00% | -100.0% |
| Q3 2020 | $910,000 | -33.4% | 306,113 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $1,366,000 | +11.0% | 295,633 | -7.6% | 0.00% | 0.0% |
| Q1 2020 | $1,231,000 | -41.6% | 319,960 | -43.1% | 0.00% | -50.0% |
| Q4 2019 | $2,107,000 | +602.3% | 562,073 | +896.5% | 0.00% | – |
| Q3 2019 | $300,000 | +64.8% | 56,406 | +18.6% | 0.00% | – |
| Q2 2019 | $182,000 | +65.5% | 47,545 | +122.5% | 0.00% | – |
| Q1 2019 | $110,000 | +279.3% | 21,364 | +42.4% | 0.00% | – |
| Q4 2018 | $29,000 | -62.8% | 14,999 | -40.1% | 0.00% | – |
| Q2 2018 | $78,000 | +4.0% | 25,048 | -19.4% | 0.00% | – |
| Q1 2018 | $75,000 | -10.7% | 31,083 | +43.7% | 0.00% | – |
| Q4 2017 | $84,000 | -30.0% | 21,627 | -54.7% | 0.00% | – |
| Q3 2017 | $120,000 | +215.8% | 47,704 | +241.3% | 0.00% | – |
| Q2 2017 | $38,000 | +22.6% | 13,979 | -12.9% | 0.00% | – |
| Q1 2017 | $31,000 | +82.4% | 16,050 | +0.3% | 0.00% | – |
| Q4 2016 | $17,000 | -89.2% | 16,005 | -88.9% | 0.00% | – |
| Q3 2016 | $157,000 | -48.0% | 143,851 | -66.2% | 0.00% | – |
| Q2 2016 | $302,000 | +162.6% | 425,076 | +333.2% | 0.00% | – |
| Q1 2016 | $115,000 | -16.1% | 98,128 | +73.9% | 0.00% | – |
| Q4 2015 | $137,000 | +31.7% | 56,428 | +62.7% | 0.00% | – |
| Q3 2015 | $104,000 | -35.8% | 34,687 | -11.3% | 0.00% | – |
| Q2 2015 | $162,000 | -76.6% | 39,099 | -75.6% | 0.00% | -100.0% |
| Q1 2015 | $693,000 | +259.1% | 160,169 | +146.8% | 0.00% | – |
| Q4 2014 | $193,000 | +27.8% | 64,909 | +43.0% | 0.00% | – |
| Q3 2014 | $151,000 | +1158.3% | 45,384 | +226.5% | 0.00% | – |
| Q2 2013 | $12,000 | – | 13,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |